Johansson, Viktoria http://orcid.org/0000-0003-3775-7245
Jakobsson, Joel
Fortgang, Rebecca G.
Zetterberg, Henrik
Blennow, Kaj
Cannon, Tyrone D.
Hultman, Christina M.
Wetterberg, Lennart
Landén, Mikael
Funding for this research was provided by:
Stockholm County Council and the Karolinska Institutet (ALF 20100305, ALF 20090183)
National Institutes of Health (T.D. Cannon RO1 MH52857)
the Swedish Medical Research Council (K2014-62X-14647-12-51, K2010-61P-21568-01-4)
Stiftelsen för Strategisk Forskning (KF10-0039)
Article History
Received: 8 June 2016
Accepted: 13 December 2016
First Online: 30 December 2016
Compliance with ethical standards
:
: Tyrone Cannon is a consultant to Boehringer Ingelheim Pharmaceuticals and Kaj Blennow has served as consultant and at advisory boards for Fujirebio Europe, IBL International and Roche Diagnostics. Viktoria Johansson, Joel Jakobsson, Rebecca G Fortgang, Henrik Zetterberg, Christina M Hultman, Lennart Wetterberg, and Mikael Landén have no financial interests to declare.